The Edit logo

The Edit Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10

Best for: knowing which pharmacy fills the vial: it names The Pharmacy Hub

7.5
★★★★☆7.5/10

The Edit scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $259 a month; its compounded tirzepatide, at $349, is 30% above the $269 median among the sellers we compare.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

$200first month

then $259/mo ongoing

Same price at every dose

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

See plans →

Prices checked October 2026

Compare top-rated alternatives ↓

Every treatment page carries its price in the open, and beginning requires no card on file. Austin is home to The Edit Health LLC, a management services organization under Texas law, selling GHK-Cu, glutathione, sermorelin and NAD+ protocols beside compounded tirzepatide and semaglutide for weight loss. An independent practice affiliated with it, Arora Health & Aesthetics, does the prescribing; a named partner in Miami, The Pharmacy Hub, does the dispensing. Spanish and English both run on the site.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $259/moPrice shown up frontFlat across dosesIncludes medication + consultAll 50 statesPharmacy namedNo FDA warning letters found

Is The Edit legit?

Yes. The Edit is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.

Is there a The Edit promo or coupon code?

The Edit has no coupon code to enter. New patients are currently quoted $200 for the first month, then $259 a month, and the discount applies on its own. Coupon sites advertising a "The Edit promo code" are not a source we can vouch for.

See how The Edit compares on our rankings of the best semaglutide providers and the best tirzepatide providers.

Vetted alternatives to The Edit

9.0/ 10
Verified partner

YourEra

Best for: semaglutide at $99/month, well below the typical price

★★★★★9.0/10

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideNAD+LegitScript Verified
Get StartedRead full YourEra review →
9.1/ 10
Verified partner

Collective

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

★★★★★9.1/10

Editorial score · methodology

$59/mo+ membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.1/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★★☆8.1/10

Editorial score · methodology

$149/mo+ care fee
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
The Edit logo
7.5 / 10
Our editorial rating
Visit The Edit →

from $259/mo · no insurance needed

The Edit at a glance

Type
GLP-1 telehealth provider
Starting price
$259/mo
Pricing model
Flat: the price stays the same as the dose goes up
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letters found

How The Edit scores

Six columns, each one computed from something The Edit has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.

Value25%

3.1/10

$349/month is 30% above the $269 median for compounded tirzepatide across the sellers we compare.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

8.0/10

A price is shown before the questionnaire starts.

Trust & Safety15%

9.0/10

It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.

Accessibility10%

10.0/10

Serves all 50 states.

Support10%

7.0/10

The price covers the medication, clinician visits and shipping.

6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

What we checked on The Edit

Last checked October 2026
  • Checked the listed price across 2 dose or plan tiers
  • Checked state coverage: all 50
  • Checked what the monthly price covers, and what it leaves out
  • Recorded which pharmacies the seller names as filling its prescriptions, with the page and date
  • Checked FDA warning letters for The Edit

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.

What signing up with The Edit involves

What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.

  1. 1The Edit shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
  2. 2The Pharmacy Hub fills the prescriptions, and The Edit names it publicly, which most sellers do not.
  3. 3The monthly price includes the medication, clinician visits and shipping.
Price shown before you start
  • Lowest ongoing monthly price: semaglutide $259, tirzepatide $349. That leaves out membership fees, first-month rates and insurance copays.
  • The Edit serves all 50 states.
  • The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.

Cancelling The Edit

Taken from the terms The Edit publishes. Terms change, so check the current policy before you subscribe.

Cancel any time
Yes
Minimum commitment
None
Refund policy
Full refund if not approved; compounded medication non-refundable once dispensed
Early-termination fee
None

Medications The Edit lists

The Edit lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.

Peptides The Edit offers

The Edit sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.

Pricing

Prices re-verified

Month-to-month, same price at every doseCompounded
$259$200/mo
Save 23% right now
semaglutide

"$200 first month, then $259 / month". Prepay tiers are billed once upfront: 3 months $575 ($192/mo), 6 months $1,065 ($178/mo).

Month-to-month, same price at every doseCompounded
$349$300/mo
Save 14% right now
tirzepatide

"$300 first month, then $349 / month". Prepay tiers are billed once upfront: 3 months $855 ($285/mo), 6 months $1,575 ($263/mo).

Check the price yourself before you pay

Every figure here comes from The Edit's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See The Edit pricing →

The Edit compounding-pharmacy partners

The Edit names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.

The Pharmacy Hub

License footprint
1 states: FL
“Prescription products are dispensed by independent licensed pharmacies, including our partner pharmacy The Pharmacy Hub (15600 NW 15th Ave, Suite C, Miami, FL 33169; (888) 958-1382; [website])”

Compare every compounding pharmacy we’ve reviewed →

In its favor

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • Names The Pharmacy Hub as the pharmacy that fills its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to The Edit

Against it

  • Semaglutide costs $259 a month, 30% above the $199 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $349 a month, 30% above the $269 median for compounded tirzepatide across the sellers we compare
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What The Edit charges

The figure The Edit leads with is $200, and it is a first-month rate. From month two the price is $259/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.

  • Compounded semaglutide: $200 first month, then $259/month
  • Compounded tirzepatide: $300 first month, then $349/month

For compounded tirzepatide, the median across the sellers we compare is $269/month, so The Edit's $349 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much. Before you pay, compare The Edit's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.

Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.

What The Edit dispenses

The Edit prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.

Safety and disclosure

The Edit tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to The Edit. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against The Edit. How we weigh oversight, disclosure and price is set out in our scoring methodology.

The Edit also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.

Who should look elsewhere

  • You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
  • You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
  • You want the FDA-approved pen specifically. Everything listed here is compounded.
  • You need insurance to cover the cost. Check whether The Edit bills your plan before you start.

It fits if

  • you want the price to stop moving as your dose climbs
  • you want a cheap way to find out whether the medication suits you before committing
  • you need access wherever you live

Our read

The Edit is a cheap way to start and an ordinary way to continue. Use the $200 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $259/month before you let it renew twice.

The Bottom Line

The Edit scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $259 a month; its compounded tirzepatide, at $349, is 30% above the $269 median among the sellers we compare.

Score: 7.5/10Best for: knowing which pharmacy fills the vial: it names The Pharmacy HubFrom: $259/mo

Before you pay The Edit

Starting at $259 a month. Check today's price, then start the intake.

Where The Edit is the wrong choice

No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
  • If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
  • If you want a human checking in, not just a prescription, consider Eden.

If none of these fits, our guide to alternatives to The Edit sets more sellers in the same category beside The Edit on price, states and what the price includes.

Frequently Asked Questions

Every treatment page carries its price in the open, and beginning requires no card on file. Austin is home to The Edit Health LLC, a management services organization under Texas law, selling GHK-Cu, glutathione, sermorelin and NAD+ protocols beside compounded tirzepatide and semaglutide for weight loss. An independent practice affiliated with it, Arora Health & Aesthetics, does the prescribing; a named partner in Miami, The Pharmacy Hub, does the dispensing. Spanish and English both run on the site. We rate it 7.5/10 overall.
The standing rate at The Edit is $259 a month. The $200 figure is a first month, not what you pay from month two. Cost also moves with the medication and the dose, so read the row in the pricing table above that matches yours.
The Edit says it treats patients in all 50 states.
The Edit lists compounded semaglutide and compounded tirzepatide.
The Edit lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether The Edit bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
The Edit says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. New patients are currently quoted $200 for the first month. The Edit runs that whole sequence on its own site.
We found no FDA warning letters issued to The Edit. Before you buy, weigh these: Semaglutide costs $259 a month, 30% above the $199 median for compounded semaglutide across the sellers we compare. Tirzepatide costs $349 a month, 30% above the $269 median for compounded tirzepatide across the sellers we compare. Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of them rules The Edit out, but each is worth settling before you pay.
Other sellers we cover include RxSpan MD, Direct Meds, and Wellorithm. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.

How to check The Edit yourself

Every seller that ships to your state, side by side: Massachusetts, Mississippi, Missouri, Nebraska, New Mexico, North Dakota, South Carolina, Wyoming and every other state.

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this The Edit review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of October 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.

See The Edit's current pricing

Plans start at $200 a month. Whether you qualify is a clinician's decision, made after your intake.